Ann: Webinar Updated Commercial Research for Sofpironium Bromide, page-50

I think I recall on a post someone saying how the drug I much more expensive than in Japan?

I'm not sure if anyone else picked this up......or maybe I have it completely wrong.

I was looking back at the Hartley's report 17 August 22 about SB. In particular the info/snap shot from the report below:


So 1 yen = 0.0073 USD
4874 yen (for 1 gram) = $36 USD (for 1 gram).........with 20 grams per bottle - this equates to $720 USD for a 20gram bottle(which is only 2 weeks supply)

This is only the 5% SB currently in Japan.

The Webinar yesterday mentioned around $700/month for current treatments in the US - parity or premium to this amount would be the target for our SB.
With our SB being 15% & likely with a more improved application (I know we are likely marketting it to compete with Qbrexa).

But looks to me like we could be selling ourselves short? (when this does eventuate)

Just thinking out loud here......